Evidence map›Paper›PMID 20682257›Full record

ArticleBiophysical journal2010

Linking the acetylcholine receptor-channel agonist-binding sites with the gate.

David J Cadugan, Anthony Auerbach

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Cyclic activation of endplate acetylcholine receptors.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  3. Article
  4. Article
  5. The energy and work of a ligand-gated ion channel.Journal of molecular biology · 2013
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David J CaduganDepartment of Physiology and Biophysics, State University of New York, Buffalo, New York, USA.
Anthony Auerbach
University at Buffalo, State University of New York · US

Funding

MULTIPLE ACTIVITY PATTERNS OF ACETYLCHOLINE RECEPTORSR37NS023513 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 2000 to 2013
$6.9M
Multiple Activity Patterns of Acetylcholine ReceptorsR56NS023513 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 2014 to 2014
$530k
MULTIPLE ACTIVITY PATTERNS OF ACETYLCHOLINE RECEPTORSR01NS023513 · NINDS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI AUERBACH, ANTHONY L · 1987 to 1999
–
NINDS NIH HHS NS-23513NINDS NIH HHS R01 NS023513NINDS NIH HHS R37 NS023513NINDS NIH HHS R56 NS023513
6 · The paper itself

Abstract

The gating isomerization of neuromuscular acetylcholine receptors links the rearrangements of atoms at two transmitter-binding sites with those at a distant gate region in the pore. To explore the mechanism of this reversible process, we estimated the gating rate and equilibrium constants for receptors with point mutations of alpha-subunit residues located between the binding sites and the membrane domain (N95, A96, Y127, and I49). The maximum energy change caused by a side-chain substitution at alphaA96 was huge (approximately 8.6 kcal/mol, the largest value measured so far for any alpha-subunit amino acid). A Phi-value analysis suggests that alphaA96 experiences its change in energy (structure) approximately synchronously with residues alphaY127 and alphaI49, but after the agonist molecule and other residues in loop A. Double mutant-cycle experiments show that the energy changes at alphaA96 are strongly coupled with those of alphaY127 and alphaI49. We identify a column of mutation-sensitive residues in the alpha-subunit that may be a pathway for energy transfer through the extracellular domain in the gating isomerization.

Indexed as

AnimalsBinding SitesCell LineCholinergic AgonistsHumansIon Channel GatingMiceModels, BiologicalModels, MolecularPoint MutationProtein Structure, SecondaryProtein Structure, TertiaryReceptors, CholinergicThermodynamicsCholinergic AgonistsReceptors, Cholinergic

Identifiers

PMID20682257
PMCPMC2913195
OpenAlexW1969208014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.